Cryo-Cell International, Inc.
AMEX: CCEL0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- New York Stock Exchange American
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- CEO
- David I. Portnoy
- Employees
- 82
- Headquarters
- Oldsmar, United States
- IPO year
- 1994
- Market cap
- $32.6M
- Website
- https://www.cryo-cell.com
Loading CCEL…
Loading profile data…Frequently asked questions about CCEL
What does Cryo-Cell International, Inc. (CCEL) do?
Cryo-Cell International, Inc. specializes in the cryogenic preservation and processing of cells, primarily focusing on collecting and storing umbilical cord blood stem cells for personal family use. The company also offers a cord tissue banking service, securing a section of the umbilical cord itself. This tissue is a valuable source of mesenchy...
Where does CCEL trade?
Cryo-Cell International, Inc. (CCEL) trades on the New York Stock Exchange American.
What sector is CCEL in?
Cryo-Cell International, Inc. (CCEL) operates in the Healthcare sector, specifically in the Medical - Care Facilities industry.
Who is the CEO of Cryo-Cell International, Inc.?
David I. Portnoy is the chief executive officer of Cryo-Cell International, Inc. (CCEL).
Where is Cryo-Cell International, Inc. headquartered?
Cryo-Cell International, Inc. is headquartered in United States.
Does CCEL pay a dividend?
Yes — Cryo-Cell International, Inc. (CCEL) paid a trailing twelve-month dividend of USD 0.60 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did CCEL go public?
Cryo-Cell International, Inc. (CCEL) completed its initial public offering in 1994.